Jean-Yves BLAY
Centre Leon Berard · Centre Léon Bérard, Lyon · Centre Léon Bérard, Lyon, France
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Jean-Yves BLAY as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 00:06 UTC. Open this list on ClinicalTrials.gov
- N/ANCT05272358 · Economic Evaluation of Sarcoma Patients Management in FranceCentre Leon Berard · unknown · Sarcoma · principal investigator
- Ph2NCT05009927 · Efficiency of Imatinib Treatment After 10 Years of Treatment in Patients With Gastrointestinal Stromal Tumours (GIST) (Gist-Ten)Centre Leon Berard · recruiting · Metastatic Gastrointestinal Stromal Tumor (GIST), C-KIT Mutation, Advanced Gastrointestinal Stromal Tumor (GIST) · principal investigator
- N/ANCT04921553 · Real Word European Registry of NTRK Fusions and Other Rare Actionable Fusions (TRacKING)Centre Leon Berard · unknown · Cancer, Cancer Metastatic, NTRK Gene Fusion Overexpression · principal investigator
- Ph2NCT04333914 · Prospective Study in Patients With Advanced or Metastatic Cancer and SARS-CoV-2 InfectionCentre Leon Berard · completed · SARS-CoV-2 (COVID-19) Infection, Advanced or Metastatic Hematological or Solid Tumor · principal investigator
- Ph2NCT04116541 · A Study Evaluating the Activity of Anti-cancer Treatments Targeting Tumor Molecular Alterations/Characteristics in Advanced / Metastatic Tumors.Centre Leon Berard · recruiting · Malignant Solid Tumor · principal investigator
- N/ANCT04055220 · Efficacy and Safety of Regorafenib as Maintenance Therapy After First-line Treatment in Patients With Bone SarcomasCentre Leon Berard · recruiting · Bone Sarcoma, Osteosarcoma, Ewing Sarcoma · principal investigator
- N/ANCT03978039 · National Clinical and Biological Sarcoma Database : An Initiative of the French Sarcoma GroupInstitut Bergonié · recruiting · Sarcoma · study chair
- Ph2NCT03474094 · Clinical and Biological Activity of an Anti-PD-L1 (Atezolizumab) in Operable Localised Soft Tissue Sarcomas Patients to be Treated With RadiotherapyCentre Leon Berard · active not recruiting · Sarcoma,Soft Tissue · principal investigator
- Ph3NCT02847429 · Randomized Trial of Crenolanib in Subjects With D842V Mutated GISTArog Pharmaceuticals, Inc. · unknown · GIST With D842V Mutated PDGFRA Gene · principal investigator
- Ph3NCT02260505 · Efficiency of Imatinib Treatment Maintenance or Interruption After 3 Years of Adjuvant Treatment in Patients With Gastrointestinal Stromal Tumours (GIST)Centre Leon Berard · completed · Gastrointestinal Stromal Tumors, Resected Gastrointestinal Stromal Tumors, Non-metastatic · principal investigator
- Ph2NCT02066285 · Trial of Pazopanib in Patients With Solitary Fibrous Tumor and Extraskeletal Myxoid ChondrosarcomaGrupo Espanol de Investigacion en Sarcomas · completed · Solitary Fibrous Tumor, Extraskeletal Myxoid Chondrosarcoma
- Ph2NCT02029001 · Adapting Treatment to the Tumor Molecular Alterations for Patients With Advanced Solid Tumors: MyOwnSpecificTreatmentCentre Leon Berard · recruiting · Malignant Solid Neoplasms · principal investigator
- Ph2NCT02008019 · A Phase II Study of EVEROLIMUS in Patients With Primary or Relapsed ChondrosarcomasCentre Leon Berard · suspended · Chondrosarcoma · principal investigator
- N/ANCT01774409 · Program to Establish the Genetic and Immunologic Profile of Patient's Tumor for All Types of Advanced CancerCentre Leon Berard · unknown · Neoplasms · principal investigator
- Ph1NCT01469975 · First in Man Study Investigating the Biodistribution, the Safety and Optimal Recommended Dose of a New Radiolabelled Monoclonal Antibody Targeting Frizzled Homolog 10Centre Leon Berard · terminated · Sarcoma, Synovial · principal investigator
- Ph2NCT01323400 · Efficacy of Pazopanib in Gastrointestinal Stromal Tumors (GIST)Centre Leon Berard · completed · GIST · principal investigator
- Ph1NCT01308034 · Study of Continuous Dosing of Sunitinib in Non GIST Sarcomas With Concomitant RadiotherapyCentre Leon Berard · completed · Non GIST Sarcomas
- Ph2NCT01261429 · Study of Nilotinib Efficacy in Pigmented Villo-Nodular Synovitis/ Tenosynovial Giant Cell Tumour (PVNS/TGCT)Centre Leon Berard · completed · Pigmented Villonodular Synovitis
- Ph2NCT01222767 · Study of Zalypsis® (PM00104) in Patients With Unresectable Locally Advanced and/or Metastatic Ewing Family of Tumors (EFT) Progressing After at Least One Prior Line of ChemotherapyPharmaMar · completed · Ewing's Sarcoma, Primitive Neuroectodermal Tumor (PNET), Askin's Tumor of the Chest Wall
- Ph3NCT00367861 · Prospective Multicentric Randomized Study of Glivec® in Advanced GIST Expressing C-kit: Interruption After 5 Years vs MaintenanceCentre Leon Berard · completed · Sarcoma, Gastro-intestinal Stromal Tumors (GIST)
- Ph1/Ph2NCT00287846 · Imatinib Mesylate in Treating Patients With Recurrent or Refractory FibromatosisUNICANCER · completed · Desmoid Tumor · study chair
- Ph2NCT00052754 · Gefitinib in Treating Patients With Locally Advanced or Metastatic Synovial SarcomaEuropean Organisation for Research and Treatment of Cancer - EORTC · completed · Sarcoma · study chair
Grants
NIH projects from RePORTER, fetched 2026-11-12 00:06 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
Clinical-trial papers with this author name, ranked by citations from NIH iCite, fetched 2026-11-12 00:06 UTC. The ranking covers the 200 most relevant of 229 PubMed records, and a shared surname and initials can bring in a namesake. All 229 on PubMed
- Pazopanib for metastatic soft-tissue sarcoma (PALETTE): a randomised, double-blind, placebo-controlled phase 3 trial.Lancet · 20121,700 citationsRCR 48.7
- Vemurafenib in Multiple Nonmelanoma Cancers with BRAF V600 Mutations.N Engl J Med · 20151,444 citationsRCR 41.8
- Progression-free survival in gastrointestinal stromal tumours with high-dose imatinib: randomised trial.Lancet · 20041,314 citationsRCR 26.1
- 1,120 citationsRCR 30.4
- 974 citationsRCR 30.9
- KIT mutations and dose selection for imatinib in patients with advanced gastrointestinal stromal tumours.Eur J Cancer · 2006688 citationsRCR 14.8
- 591 citationsRCR 21.6
- 563 citationsRCR 13.5
- Denosumab in patients with giant-cell tumour of bone: an open-label, phase 2 study.Lancet Oncol · 2010527 citationsRCR 14.8
- Phase II trial of weekly paclitaxel for unresectable angiosarcoma: the ANGIOTAX Study.J Clin Oncol · 2008504 citationsRCR 12.9